Clinical efficacy of low dose recombinant tissue-type plasminogen activator for the treatment of acute intermediate-risk pulmonary embolism. [electronic resource]
Producer: 20190201Description: 1090-1095 p. digitalISSN:- 1658-3175
- Acute Disease
- Aged
- Anticoagulants -- therapeutic use
- Arterial Pressure -- drug effects
- Female
- Fibrinolytic Agents -- therapeutic use
- Heparin, Low-Molecular-Weight -- therapeutic use
- Humans
- Male
- Middle Aged
- Pulmonary Artery
- Pulmonary Embolism -- drug therapy
- Recombinant Proteins -- therapeutic use
- Systole
- Tissue Plasminogen Activator -- therapeutic use
No physical items for this record
Publication Type: Comparative Study; Journal Article; Randomized Controlled Trial
There are no comments on this title.
Log in to your account to post a comment.